Trump admin axed 383 active clinical trials, dumping over 74K participants

Share via:



Trump admin axed 383 active clinical trials, dumping over 74K participants

“A betrayal”

Jena and colleagues examined the greater context, comparing the number of cancelled trials in each treatment category to the total number of all funded trials in those categories. For instance, while cancer trials made up 30 percent of the 383 cancelled trials, the 118 cancelled cancer trials accounted for only 2.7 percent of the total 4,424 cancer trials funded in the study period. The cancelled infectious disease trials, on the other hand, accounted for over 14…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Trump admin axed 383 active clinical trials, dumping over 74K participants



Trump admin axed 383 active clinical trials, dumping over 74K participants

“A betrayal”

Jena and colleagues examined the greater context, comparing the number of cancelled trials in each treatment category to the total number of all funded trials in those categories. For instance, while cancer trials made up 30 percent of the 383 cancelled trials, the 118 cancelled cancer trials accounted for only 2.7 percent of the total 4,424 cancer trials funded in the study period. The cancelled infectious disease trials, on the other hand, accounted for over 14…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

Intense Technologies Closes Q3 FY26 with INR 34 Cr...

Hyderabad (Telangana) , January 13: Intense Technologies Limited...

Vidyasvam Announces New Online Samskṛta Workshop Based on the...

Bengaluru (Karnataka) , January 13: Immersive program begins...

Ammobia says it has reinvented a century-old technology

Ammonia might be the world’s most underappreciated chemical....

Popular

iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv iptv